Previous studies have described the presence of KNG1 and CCKAR as biomarkers of various types of cancer, such as thyroid cancer [36, 37], liver cancer [38], ovarian cancer [39], and cholangiocarcinoma [40]. This evidence concerns the gene KNG1 and ovarian cancer.